NEW YORK (GenomeWeb) – Agilent Technologies today announced the completion of its acquisition of Seahorse Bioscience.
Agilent said in a statement that Seahorse's technology for measuring cell metabolism and bioenergetics complements Agilent's separations and mass spectrometry business. The approximately 200 Seahorse employees are now a part of the Mass Spectrometry Division of the Life Sciences and Applied Markets Group.
Agilent did not disclose the final purchase price; however, it announced a definitive agreement to buy Billerica, Massachusetts-based Seahorse in September, for $235 million in cash.